IPRATECH
ActiveSummary
IPRATECH has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.6m and a net result of €98,194. Equity has been growing by about 7.7% per year since 2018. Its solvency ranks better than 38% of 239 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Overview
Official details
Source: KBO- Status
- Active since 28-11-2007 Normal situation
- Activity
- Research and development on biotechnology NACE 72101
- Joint committee
- 200 Auxiliary committee for white-collar workers · annual accounts 2022
- Establishment unit
- 2.166.840.141 7000 Mons, since 26-11-2007
- Financial year end
- 31 December
- Peppol
- Reachable since 12-05-2025
Board and ownership
- David SERGEANTManaging director
- CUBETA JérémieDirector · since 30-03-2025
- ESTEBAN GeoffreyDirector · since 30-03-2025
- Auditor
- PRAGMA AUDIT
- IMBC SPINNOVA14.92%30-06-2025 annual accounts of IMBC SPINNOVA
- VEOSIS5%· score 8430-06-2025 annual accounts of VEOSIS
- Holdings
- Shares in 3 companies including APICELLS INC and EMMA
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.8%
- Gross margin
- €1.5m
- ▲ 57.6%
- Turnover
- ≈ €2.7m
- estimated
- Profit
- €98,194
- ▼ 24.8%
- Equity
- €1.6m
- ▲ 7.4%
- Total assets
- €4.3m
- ▲ 65.0%
- Employees on 31-12-2025
- 15
- ▼ 11.8%
- 2025 accounts filed 77 days after the deadline
Score breakdownraises riskLiquidity: current ratio 1.01, cash €45,690Last filed accounts filed 77 days late; 2 of the last 3 accounts latelowers riskFounded in 2007Figures for financial year 2025 (filed on 16-10-2026)Show the evidence
Checked score
About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, small). It does better than 39% of them on solvency, 19% on liquidity, 52% on profitability and 51% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 13 days after the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
Key points
- Positive: 8 profitable years in a rowprofit 2025: €98,194 8 years View
- Merger with EMMAmerger on 05-05-2026 2026 View
- Mortgage mandates, new in 202560.7% of equity · not in the 2024 accounts €950,000 View
- Positive: More staff in 2025from 11 FTE to 15.6 FTE ▲ 41.8% View
- Heads a groupcompanies controlled 3 View
Recent changes
- · Gazette deed Merger: IPRATECH takes over EMMA“toutes activités se rapportant à: - L'exercice d'activité de recherche et de développement de procédés…” (deed in French) · The company holds all the shares of EMMA
- · Gazette deed 1 director appointed, 3 directors reappointedReappointments: David SERGEANT, POSKIN Thierry and 2 others · Appointment: CUBETA Jérémie (director)
- · Gazette deed Merger proposal: IPRATECH takes over EMMAThe company holds all the shares of EMMA
Comparable companies
These companies have the same main activity as IPRATECH: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €2.3m and €9.6m, founded between 1998 and 2014.
| Company | Total assets | Gross margin |
|---|---|---|
| IPRATECH Charleroi | €4.3m | €1.5m |
| FluidDa Kontich | €5.5m | €2.0m |
| NewMilkLab Ghent | €2.3m | €2.4m |
| TOKU-E EU Ghent | €4.2m | €1.0m |
| BIO-SOURCING Liège | €6.6m | €1.6m |
| OOGINSTITUUT Aalst | €2.4m | €2.8m |
| ImmunXperts Charleroi | €9.6m | €0.4m |
Key facts about IPRATECH
- What is the company number of IPRATECH?
- The company number of IPRATECH is 0893.778.586. The VAT number is the same number with BE in front: BE 0893.778.586.
- Where is IPRATECH based?
- The registered office is at Avenue Jean Mermoz 32, 6041 Charleroi.Company details
- What does IPRATECH do?
- According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
- What is the legal form of IPRATECH?
- IPRATECH is a public limited company (NV).
- When was IPRATECH founded?
- IPRATECH was founded on 28-11-2007.
- Is IPRATECH still active?
- Yes, IPRATECH is an active enterprise in the KBO register.
- How many employees does IPRATECH have?
- IPRATECH had an average of 15.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does IPRATECH fall under?
- In its 2022 annual accounts, IPRATECH states joint committee 200 (Auxiliary committee for white-collar workers).
- What is the turnover of IPRATECH?
- The turnover in financial year 2025 is ≈ €2.7m. This figure is estimated from the gross margin of €1.5m and 1,584 comparable companies of the same size. It probably lies between €1.8m and €4.4m. It is a rough estimate.
- Is IPRATECH profitable?
- In financial year 2025, IPRATECH made a profit of €98,194.
- Where can I find the annual accounts of IPRATECH?
- IPRATECH filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of IPRATECH due?
- IPRATECH must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.